-
Product Insights
NewLikelihood of Approval Analysis for Female Infertility
Overview How likely is it that the drugs in Female Infertility will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Female Infertility Overview Female infertility refers to infertility in women. Causes or...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Progesterone in Female Infertility
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Progesterone in Female Infertility report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Progesterone in Female Infertility Drug Details: Progesterone (Prontogest / Lutogin / Lubion...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Follitropin Delta in Women Infertility
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Follitropin Delta in Women Infertility report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Follitropin Delta in Women Infertility Drug Details: Follitropin delta (Rekovelle) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PAM-8 in Women Infertility
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PAM-8 in Women Infertility report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PAM-8 in Women Infertility Drug Details: PAM-8 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Umbilical Cord Mesenchymal Stem Cells in Women Infertility
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Umbilical Cord Mesenchymal Stem Cells in Women Infertility report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Umbilical Cord Mesenchymal Stem Cells in Women Infertility...
-
Sector Analysis
Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Report Overview The Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests market size was $2.81 billion in 2023. The market will grow at a CAGR of less than 1% during 2023-2033. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia Trachomatis. In women, Chlamydia Trachomatis infections are often asymptomatic. However, if left untreated they can cause pelvic inflammatory disease (PID), which, in turn, can lead to additional complications such as infertility, ectopic...
-
Product Insights
NewEndometriosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Endometriosis Clinical Trial Report Overview A total of 812 Endometriosis clinical trials were conducted as of February 2024. The Endometriosis clinical trial report provides a comprehensive understanding of the Endometriosis clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor types and the prominent sponsors associated with the trials. Key Regions ·       North America ·       Europe ·       Asia-Pacific ·       ...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Elenagen in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Elenagen in Gastric Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Elenagen in Gastric Cancer Drug Details: Elenagen is under development for the...
-
Product Insights
NewReproductive Health Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Reproductive Health Devices Pipeline Market Report Overview Endometrial ablation devices, female sterilization devices, reversible contraceptive devices, and assisted reproductive technology devices are the main categories of reproductive health devices. The reproductive health devices pipeline report provides comprehensive information about the main products with their comparative segment-wise analysis at various stages of development. The report also covers the regional and country-wise reproductive health devices clinical trials outlook. The regulatory paths followed for conducting the reproductive health devices pipeline research are also...
-
Sector Analysis
Assisted Reproductive Technology (ART) Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Assisted Reproductive Technology Devices Market Report Overview The global Assisted Reproductive Technology Devices market size was $282.9 million in 2023. Factors such as technical advances and the increasing geriatric population will drive the market growth at a CAGR of more than 4% from 2023 to 2033. Assisted reproductive technology (ART) refers to reproductive health procedures that help infertile women achieve pregnancy. These techniques primarily include in vitro fertilization (IVF), and intrauterine insemination (IUI). Both female and male infertility are epidemiological...